Redmond Cavan M. 4
4 · OncoCyte Corp · Filed Sep 4, 2018
Insider Transaction Report
Form 4
Redmond Cavan M.
Director
Transactions
- Award
Option to Purchase Common Stock
2018-08-30+50,000→ 50,000 totalExercise: $2.40Exp: 2028-08-29→ Common Stock (50,000 underlying)
Holdings
- 52,447
Common Stock, no par value
Footnotes (1)
- [F1]Options shall vest one year from the date of grant, subject to the director's continued service as a director of the Company or a subsidiary from the date of grant until the vesting date or, if earlier, until the next annual meeting of shareholders.